TY - JOUR
T1 - Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
AU - On behalf of the Egyptian Liver Cancer Committee Study Group
AU - Omar, Ashraf
AU - Kaseb, Ahmed
AU - Elbaz, Tamer
AU - El-Kassas, Mohamed
AU - El Fouly, Amr
AU - Hanno, Abdel Fatah
AU - El Dorry, Ahmed
AU - Hosni, Ahmed
AU - Helmy, Amr
AU - Saad, Amr S.
AU - Alolayan, Ashwaq
AU - Eysa, Basem Elsayed
AU - Hamada, Emad
AU - Azim, Hamdy
AU - Khattab, Hany
AU - Elghazaly, Hesham
AU - Tawfik, Hesham
AU - Ayoub, Hisham
AU - Khaled, Hussein
AU - Saadeldin, Ibtessam
AU - Waked, Imam
AU - Barakat, Eman M.F.
AU - El Meteini, Mahmoud
AU - Hamed Shaaban, Mohamed
AU - EzzElarab, Mohamed
AU - Fathy, Mohamed
AU - Shaker, Mohamed
AU - Sobhi, Mohamed
AU - Shaker, Mohamed Kamal
AU - ElGharib, Mohamed
AU - Abdullah, Mohammed
AU - Mokhtar, Mohesn
AU - Elshazli, Mostafa
AU - Heikal, Omar Mohamed Khaleil
AU - Hetta, Osama
AU - ElWakil, Reda Mahmoud
AU - Abdel Wahab, Sameh
AU - Eid, Samir Shehata
AU - Rostom, Yousri
N1 - Publisher Copyright:
© 2023 Omar et al.
PY - 2023
Y1 - 2023
N2 - Globally, hepatocellular carcinoma (HCC) is the fourth most common cause of death from cancer. The prevalence of this pathology, which has been on the rise in the last 30 years, has been predicted to continue increasing. HCC is the most common cause of cancer-related morbidity and mortality in Egypt and is also the most common cancer in males. Chronic liver diseases, including chronic hepatitis C, which is a primary health concern in Egypt, are considered major risk factors for HCC. However, HCC surveillance is recommended for patients with chronic hepatitis B virus (HBV) and liver cirrhosis; those above 40 with HBV but without cirrhosis; individuals with hepatitis D co-infection or a family history of HCC; and Nonalcoholic fatty liver disease (NAFLD) patients exhibiting significant fibrosis or cirrhosis. Several international guidelines aid physicians in the management of HCC. However, the availability and cost of diagnostic modalities and treatment options vary from one country to another. Therefore, the current guidelines aim to standardize the management of HCC in Egypt. The recommendations presented in this report represent the current management strategy at HCC treatment centers in Egypt. Recommendations were developed by an expert panel consisting of hepatologists, oncologists, gastroenterologists, surgeons, pathologists, and radiologists working under the umbrella of the Egyptian Society of Liver Cancer. The recommendations, which are based on the currently available local diagnostic aids and treatments in the country, include recommendations for future prospects.
AB - Globally, hepatocellular carcinoma (HCC) is the fourth most common cause of death from cancer. The prevalence of this pathology, which has been on the rise in the last 30 years, has been predicted to continue increasing. HCC is the most common cause of cancer-related morbidity and mortality in Egypt and is also the most common cancer in males. Chronic liver diseases, including chronic hepatitis C, which is a primary health concern in Egypt, are considered major risk factors for HCC. However, HCC surveillance is recommended for patients with chronic hepatitis B virus (HBV) and liver cirrhosis; those above 40 with HBV but without cirrhosis; individuals with hepatitis D co-infection or a family history of HCC; and Nonalcoholic fatty liver disease (NAFLD) patients exhibiting significant fibrosis or cirrhosis. Several international guidelines aid physicians in the management of HCC. However, the availability and cost of diagnostic modalities and treatment options vary from one country to another. Therefore, the current guidelines aim to standardize the management of HCC in Egypt. The recommendations presented in this report represent the current management strategy at HCC treatment centers in Egypt. Recommendations were developed by an expert panel consisting of hepatologists, oncologists, gastroenterologists, surgeons, pathologists, and radiologists working under the umbrella of the Egyptian Society of Liver Cancer. The recommendations, which are based on the currently available local diagnostic aids and treatments in the country, include recommendations for future prospects.
KW - clinical recommendations
KW - Egypt
KW - Egyptian society of liver cancer
KW - guidelines
KW - hepatitis c virus
KW - hepatocellular carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85171839145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85171839145&partnerID=8YFLogxK
U2 - 10.2147/JHC.S404424
DO - 10.2147/JHC.S404424
M3 - Review article
C2 - 37744303
AN - SCOPUS:85171839145
SN - 2253-5969
VL - 10
SP - 1547
EP - 1571
JO - Journal of Hepatocellular Carcinoma
JF - Journal of Hepatocellular Carcinoma
ER -